MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Lannett Company Company Profile (NYSE:LCI)

Consensus Ratings for Lannett Company (NYSE:LCI) (?)
Ratings Breakdown: 1 Sell Rating(s), 1 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Hold (Score: 2.40)
Consensus Price Target: $31.10 (28.35% upside)

Analysts' Ratings History for Lannett Company (NYSE:LCI)
Show:
DateFirmActionRatingPrice TargetActions
5/14/2016OppenheimerReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/25/2016SusquehannaLower Price Target$37.00 -> $30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/25/2016Craig HallumLower Price TargetBuy$35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/24/2016Roth CapitalLower Price TargetBuy$30.00 -> $27.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/24/2016Canaccord GenuityDowngradeBuy -> Sell$28.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/27/2016Raymond JamesLower Price Target$45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/27/2014 forward)
Earnings History for Lannett Company (NYSE:LCI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/23/2016        
5/3/2016Q316$0.63$0.75$160.49 million$163.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/3/2016Q216$0.94$0.95$141.62 million$127.06 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2015Q116$0.89$0.99$103.90 million$106.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/25/2015Q415$0.86$0.91$99.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2015Q315$0.94$0.97$101.10 million$99.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/4/2015Q215$1.06$1.21$102.95 million$114.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/3/2014Q115$0.79$0.94$91.40 million$93.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/27/2014Q414$0.54$0.64$79.50 million$80.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2014Q314$0.60$0.63$84.50 million$80.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/6/2014Q214$0.39$0.46$62.21 million$67.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2013Q114$0.13$0.22$41.14 million$45.82 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
9/10/2013Q4 2013$0.07$0.12$37.89 million$40.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2013Q3 2013$0.13$0.14$35.14 million$39.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/7/2013Q2 2013$0.05$0.10$33.53 million$36.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/8/2012Q113$0.05$0.07$33.76 million$35.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Lannett Company (NYSE:LCI)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20165$0.60$0.91$0.77
Q2 20167$0.62$1.10$0.93
Q4 20163$0.60$0.69$0.63
Q1 20171$0.70$0.70$0.70
Q2 20171$0.75$0.75$0.75
Q3 20171$0.80$0.80$0.80
Q4 20171$0.86$0.86$0.86
(Data provided by Zacks Investment Research)
Dividend History for Lannett Company (NYSE:LCI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Lannett Company (NYSE:LCI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/23/2016Robert EhlingerVPSell37,141$25.06$930,753.46View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/20/2016Robert EhlingerVPSell62,859$25.40$1,596,618.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/1/2016Robert EhlingerVPSell69,247$25.41$1,759,566.27View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/5/2016Arthur P BedrosianCEOBuy4,500$24.91$112,095.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/5/2016David A DrabikDirectorBuy1,277$24.74$31,592.98View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/5/2016Kevin SmithVPBuy1,500$24.75$37,125.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/5/2016Martin P GalvanCFOBuy3,000$24.65$73,950.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/15/2015Arthur P BedrosianCEOSell5,000$55.64$278,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/8/2015John AbtVPBuy1,000$54.77$54,770.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/17/2015Arthur P BedrosianCEOSell5,000$52.81$264,050.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/15/2015Arthur P BedrosianCEOSell5,000$61.92$309,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/15/2015Arthur P BedrosianCEOSell5,000$56.31$281,550.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/15/2015Arthur P BedrosianCEOSell5,000$53.27$266,350.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/15/2015Arthur P BedrosianCEOSell5,000$69.43$347,150.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/16/2015Arthur P BedrosianCEOSell5,000$65.23$326,150.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/16/2015William SchreckCOOSell134,635$64.99$8,749,928.65View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/6/2015William SchreckCOOSell50,000$63.35$3,167,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/18/2015David A DrabikDirectorSell12,500$61.55$769,375.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/17/2015Arthur P BedrosianCEOSell5,000$59.89$299,450.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/17/2015G. Michael LandisInsiderSell11,500$58.60$673,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/13/2015Jeffrey FarberDirectorSell35,000$58.18$2,036,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/11/2015Kevin SmithVPSell109,436$56.51$6,184,228.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/9/2015David FarberMajor ShareholderSell2,500$55.00$137,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/9/2015Kevin SmithVPSell53,534$55.36$2,963,642.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/6/2015G. Michael LandisInsiderSell12,049$52.93$637,753.57View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/26/2015David FarberMajor ShareholderSell7,500$50.00$375,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/15/2015Arthur P BedrosianCEOSell5,000$43.50$217,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/15/2014Arthur P BedrosianCEOSell5,000$43.81$219,050.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/10/2014Martin P GalvanCFOBuy1,000$42.40$42,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/8/2014Ernest SaboVPSell6,000$48.03$288,180.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/27/2014David FarberMajor ShareholderSell7,500$50.00$375,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/16/2014Arthur P BedrosianCEOSell5,000$40.05$200,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/18/2014David FarberMajor ShareholderSell5,000$41.30$206,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/15/2014Arthur P BedrosianCEOSell5,000$47.19$235,950.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/23/2014David FarberMajor ShareholderSell7,500$50.00$375,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/16/2014Arthur P BedrosianCEOSell5,000$46.96$234,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/16/2014David FarberMajor ShareholderSell10,000$43.53$435,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/16/2014Paul TaveiraDirectorSell1,000$46.94$46,940.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/17/2014William SchreckCOOSell16,600$43.85$727,910.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/12/2014William SchreckCOOSell55,563$43.31$2,406,433.53View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/20/2014Kevin SmithVPSell64,665$45.11$2,917,038.15View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/13/2014Kevin SmithVPSell20,000$40.48$809,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/13/2013Arthur BedrosianCEOBuy5,000$27.85$139,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/13/2013Martin GalvanCFOBuy3,000$26.90$80,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/14/2013Kevin SmithVPSell24,984$11.86$296,310.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2013Kevin SmithVPSell41,929$11.80$494,762.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/10/2013Ernest SaboVPSell15,000$11.29$169,350.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/14/2013Paul TaveiraDirectorBuy1,000$9.73$9,730.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/13/2013Martin P GalvanCFOBuy4,000$6.88$27,520.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Lannett Company (NYSE:LCI)
DateHeadline
06/24/16 07:22 AM3 Healthcare Stocks That Are Looking Cheap -
06/23/16 05:20 PMLannett Co Inc (NYSE:LCI) Current Analyst Ratings - Fiscal Standard
06/23/16 05:20 PMMy Most Bearish Valuation Of Lannett - Seeking Alpha
06/21/16 04:35 PMLannett : Draws Bearish Attention After Forming Double Bottom
06/20/16 07:43 AMStock Earnings Analysis: Lannett Company, Inc. (NYSE:LCI) - iStreetWire
06/20/16 07:43 AMLannett Co Inc (NYSE:LCI) Analyst Price Targets For The Coming Week - Fiscal Standard
06/20/16 06:09 AMLannett Completes Repurchase Of Remaining $200 Million Of 12% Senior Notes - [at noodls] - PHILADELPHIA, June 20, 2016/PRNewswire / -- Lannett Company, Inc. (NYSE: LCI) today announced that it has completed the repurchase of the remaining $200 millionof the 12% Senior Notes due in 2023, after ...
06/17/16 04:47 PMOverview of Price Moves: Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) , Lannett Co Inc (NYSE:LCI) - Street Updates
06/15/16 04:54 PMComprehensive Report on: Ocean Rig UDW LLC (NASDAQ:ORIG), Lannett Company, Inc. (NYSE:LCI) - Beacon Chronicle
06/15/16 02:12 PMLannett Company, Inc. -- Moody's Affirms Lannett's B2 CFR; Senior Secured Rating Downgraded to B2; Stable outlook -
06/15/16 09:32 AMTake a look at Price Fluctuations: Orexigen Therapeutics, Inc. (NASDAQ:OREX) , Lannett Co Inc (NYSE:LCI) - Street Updates
06/15/16 09:32 AMLannett Company, Inc. (NYSE:LCI) revealed it received approval from the US FDA of its New Drug Application - Inside Trade
06/14/16 04:43 PMLannett Gets FDA Approval For Neomycin Sulfate Tablets - Benzinga
06/14/16 10:00 AM$200M buyback: Lannett wiping more high-interest debt off its balance sheet -
06/14/16 06:09 AMLannett To Amend Credit Agreement To Repurchase Remaining $200 Million Of 12% Senior Notes - [at noodls] - PHILADELPHIA, June 14, 2016/PRNewswire / -- Lannett Company, Inc. (NYSE: LCI) today announced that it has reached an agreement with an existing lender to raise an incremental $150 millionTerm Loan B, and ...
06/14/16 05:56 AM6:56 am Lannett to raise an incremental $150 mln Term Loan B from an existing lender to repurchase the remaining $200 mln of the 12% Senior Notes due in 2023 -
06/13/16 04:35 PMLannett gets FDA approval for generic version of neomycin sulphate tablets
06/13/16 03:14 PMLANNETT CO INC Files SEC form 8-K, Regulation FD Disclosure -
06/13/16 07:47 AMLannett Co Inc (NYSE:LCI) Earns Rating Score Of 1.6 - RealistInvestor.com
06/13/16 06:34 AMLannett Gets FDA Approval For Neomycin Sulfate Tablets -
06/13/16 06:19 AMLannett Receives FDA Approval For Neomycin Sulfate Tablets USP, 500 mg - [at noodls] - PHILADELPHIA, June 13, 2016/PRNewswire / -- Lannett Company, Inc. (NYSE: LCI) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug ...
06/09/16 10:30 AMThis Winning Investing Strategy Defies Logic -
06/09/16 05:30 AMDo Charts Agree With Bears on the Most-Shorted Stocks? -
06/08/16 05:15 PMLannett Co Inc (NYSE:LCI) Has $0.135 Millions Outstanding Debt Accrued - RealistInvestor.com
06/08/16 05:15 PMLANNETT COMPANY INC. (NYSE:LCI) Financial Condition Compared to S&P 500 - CML News
06/04/16 04:54 PMMost recent Analysts Rating report: Lannett Co Inc (NYSE:LCI) , Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) - Street Updates
06/03/16 05:19 PMStock Review and Earnings Check on Lannett Co Inc (NYSE:LCI) - HNN
06/02/16 07:47 AMLannett Co Inc (NYSE:LCI) Stock Update & Estimates - Stock Tick Tock - Lannett Co Inc (NYSE:LCI) Stock Update & EstimatesStock Tick TockThe consensus on Wall Street is expecting Lannett Co Inc (NYSE:LCI) to post earnings of $0.62 per share when the firm next reports it's fiscal quarterly results. According to the latest information available the report will likely be issued around 2016 ...and more »
05/30/16 09:56 PMLannett : Increases Again; Strong Momentum for Buyers - Lannett Company, Inc. has declined 43.30% since October 22 ... We have $28.74 PT which if reached, will make NYSE:LCI worth $179.91 million more. Out of 4 analysts covering Lannett (, 4 rate it a Buy, 0 Sell, while 1 Hold. This means 80% are positive.
05/29/16 11:19 PMStock Rating Review for Lannett Co Inc (NYSE:LCI) - HNN - Stock Rating Review for Lannett Co Inc (NYSE:LCI)HNNInvestors may choose to follow the views of professional Wall Street analysts that regularly track the company. Covering equity analysts presently have a consensus stock rating of 1.6 on shares of Lannett Co Inc (NYSE:LCI). Covering analysts will often ...and more »
05/28/16 06:14 PMLannett Completes Senior Notes Pay Down Of $50 Million - Benzinga - Lannett Completes Senior Notes Pay Down Of $50 MillionBenzingaLannett Company, Inc. LCI 3.4% revealed Friday it has completed the buyback of $50 million worth of the $250 million aggregate principal amount of the 12 percent Senior Notes due in 2023 in open market transactions. The company disclosed its intention ...Lannett Company, Inc. Increases Again; Strong Momentum for BuyersHNNLannett Completes $50 Mln Buyback of 12% Notes Due 2023 (NYSE:LCI)Sonoran Weekly ReviewLannett Completes $50 Million-Pay Down Of 12% Senior NotesPR Newswire (press release)all 5 news articles »
05/27/16 03:24 PMLANNETT CO INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits -
05/27/16 01:41 PMLannett Completes Senior Notes Pay Down Of $50 Million - Lannett Company, Inc. (NYSE: LCI) revealed Friday it has completed the buyback of $50 million worth of the $250 million aggregate principal amount of the 12 percent Senior Notes due in ...Full story available on Benzinga.com
05/27/16 09:40 AMEarnings Review and Stock Rundown for Lannett Co Inc (NYSE:LCI) - Wall Street Hints and News - Earnings Review and Stock Rundown for Lannett Co Inc (NYSE:LCI)Wall Street Hints and NewsInvestors and analysts will be paying close attention when the company posts earnings results. Earnings numbers can provide insight into a company's overall profitability. Covering equity analysts are expecting Lannett Co Inc (NYSE:LCI) to post ...and more »
05/27/16 06:07 AMLannett Completes $50 Million-Pay Down Of 12% Senior Notes - [at noodls] - PHILADELPHIA, May 27, 2016/PRNewswire / -- Lannett Company, Inc. (NYSE: LCI) today announced that it has completed the repurchase of $50 millionof the $250 millionaggregate principal amount of the 12% ...
05/26/16 06:28 PMLannett Company, Inc. (LCI) - Financial and Strategic SWOT Analysis Review - New Market Research Report - 26.05.2016 11:42:29 - New Pharmaceuticals market report from GlobalData: "Lannett Company, Inc. (LCI) - Financial and Strategic SWOT Analysis Review" (live-PR.com) - Lannett Company, Inc. (LCI) - Financial and Strategic SWOT Analysis Review provides you an ...
05/26/16 09:52 AMInvestors Attention Alert: Lannett Co Inc (NYSE:LCI) , Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) - Street Updates - Investors Attention Alert: Lannett Co Inc (NYSE:LCI) , Idera Pharmaceuticals, Inc. (NASDAQ:IDRA)Street UpdatesOn 5/25/2016, shares of Lannett Co Inc (NYSE:LCI) rose +1.30% in trading session and finally closed at $23.40. The company most recent volume stood at 729.47 thousand shares as compared to its average volume of 1.13 million shares. Over the one year ...Lannett Co To Pay Down $50 Mln of 12% Senior Notes Due 2023 to 'Significantly' Cut Interest Expense (NYSE:LCI)Sonoran Weekly ReviewLannett to pay down $50M in debtSeeking AlphaLannett To Voluntarily Pay Down $50 Million Of 12% Senior NotesPR Newswire (press release)Wall Street Hints and Newsall 5 news articles »
05/26/16 06:17 AMLannett To Voluntarily Pay Down $50 Million Of 12% Senior Notes - [at noodls] - PHILADELPHIA, May 26, 2016/PRNewswire / -- Lannett Company, Inc. (NYSE: LCI) today announced that it expects to repurchase $50 millionof the $250 millionaggregate principal amount of the 12% Senior Notes ...
05/25/16 09:45 AMLannett : Shares Increased 1.95% After High Volatility - Investors must be careful when trading such stocks. About 431,980 shares traded hands. Lannett Company, Inc. (LCI) has declined 53.43% since October 14, 2015 and is downtrending. It has underperformed by 55.72% the S&P500. The institutional sentiment ...
05/24/16 06:25 PMHealthcare Stocks in Target: Celator Pharmaceuticals Inc. (NASDAQ:CPXX) , Lannett Co Inc (NYSE:LCI) - Is stories - Healthcare Stocks in Target: Celator Pharmaceuticals Inc. (NASDAQ:CPXX) , Lannett Co Inc (NYSE:LCI)Is storiesIn most recently trading session on 5/23/2016, Lannett Co Inc (NYSE:LCI) dropped -0.80% while traded on 1.02 million shares versus it's an average volume of 1.14 million shares. The company recorded the last trade with the price of $22.32. The stock ...and more »
05/24/16 10:14 AMTarget Check and Stock Performance Recap Lannett Co Inc (NYSE:LCI) - Wall Street Hints and News - Target Check and Stock Performance Recap Lannett Co Inc (NYSE:LCI)Wall Street Hints and NewsTracking stock performance from various views may help with share evaluation. Some investors might be more focused on short-term share action while others may prefer to view long-term performance. In recent session activity, Lannett Co Inc (NYSE:LCI) ...and more »
05/23/16 11:29 PMStock Paining Investors: Lannett Company, Inc. (NYSE:LCI) - Wall Street Hints and News - Stock Paining Investors: Lannett Company, Inc. (NYSE:LCI)Wall Street Hints and NewsLannett Company, Inc. (NYSE:LCI) shares have underperformed for investors this year as the stock has dropped -58.89% for the year. Shareholders are shaking their heads and questioning their investment and pondering what their next move will be.and more »
05/23/16 06:19 PMHealthcare Stock seeking Investors: Lannett Company, Inc. (NYSE:LCI) - News Oracle - Healthcare Stock seeking Investors: Lannett Company, Inc. (NYSE:LCI)News OracleThe Company gained 10.35% and finished at $22.50. The daily volume was measured at 1.71 million shares. The 52-week high of the share price is $62.90 and the 52-week low is $16.91. The company has a market cap of $912.38 million. The stock has a ...Lannett Company, Inc. (NYSE:LCI) Earns Consensus Hold RatingiStreetWireall 2 news articles »
05/23/16 04:18 PMETF’s with exposure to Lannett Co., Inc. : May 23, 2016 -
05/23/16 03:13 PMLannett Co., Inc.: Gathering momentum, can it sustain its performance? -
05/23/16 11:26 AMHot Watch List: Cheetah Mobile Inc. (NYSE:CMCM), Lannett Company, Inc. (NYSE:LCI), Agree Realty Corp. (NYSE ... - KC Register - Hot Watch List: Cheetah Mobile Inc. (NYSE:CMCM), Lannett Company, Inc. (NYSE:LCI), Agree Realty Corp. (NYSE ...KC RegisterLannett Company, Inc. (NYSE:LCI) traded 1.71 Million shares and its share price increased 10.35% to close at $22.50. Company has 8.90% insider ownership. Lannett Company, Inc. (NYSE:LCI) quarterly performance is -11.35% while its year to date (YTD) ...and more »
05/22/16 10:52 PMStock Rating Review for Lannett Co Inc (NYSE:LCI) - Wall Street Hints and News - Stock Rating Review for Lannett Co Inc (NYSE:LCI)Wall Street Hints and NewsInvestors may choose to follow the views of professional Wall Street analysts that regularly track the company. Covering equity analysts presently have a consensus stock rating of 2.17 on shares of Lannett Co Inc (NYSE:LCI). Covering analysts will ...and more »
05/21/16 09:48 AMLannett Co. Inc. (LCI) Jumps 10.35% on May 20 - Equities.com - Lannett Co. Inc. (LCI) Jumps 10.35% on May 20Equities.comLannett Co. Inc. (LCI) was among the biggest gainers on the Russell 2000 for Friday May 20 as the stock popped 10.35% to $22.50, representing a gain of $2.11 per share. Some 1.71 million shares traded hands on 9,715 trades, compared with an average ...and more »
05/20/16 06:16 PMShare Recap and Earnings Focus on Lannett Co Inc (NYSE:LCI) - Wall Street Hints and News - Share Recap and Earnings Focus on Lannett Co Inc (NYSE:LCI)Wall Street Hints and NewsAnalysts and investors are usually very focused on company earnings numbers when they are released. Company earnings are a good way to evaluate the profitability of the company. Presently, covering analysts are anticipating Lannett Co Inc (NYSE:LCI) to ...and more »
05/18/16 11:28 PMTraders Targeted Movers: Lannett Co Inc (NYSE:LCI) , Zafgen, Inc. (NASDAQ:ZFGN) - Street Updates - Traders Targeted Movers: Lannett Co Inc (NYSE:LCI) , Zafgen, Inc. (NASDAQ:ZFGN)Street UpdatesOn 5/13/2016, shares of Lannett Co Inc (NYSE:LCI) rose +3.49% in trading session and finally closed at $18.96. The company most recent volume stood at 728.09 thousand shares as compared to its average volume of 1.13 million shares. Over the one year ...Lannett Comp (NYSE:LCI) Shorted Shares Increased 3.69% After Market SellingFranklin Independentall 3 news articles »
About Lannett Company

Lannett Company logoLannett Company, Inc. develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. The Company's products include Levothyroxine Sodium tablets, Digoxin tablets, Butalbital products, Ursodiol capsules and pain management products. Levothyroxine Sodium tablets are produced and marketed with around 12 varying potencies. Digoxin tablets are produced and marketed with approximately two different potencies. It distributes around three products containing Butalbital. Ursodiol capsules are produced and marketed in 300 milligram capsules. The Company offers a range of pain management products, such as Cocaine Topical Solution (C-Topical), Morphine Sulfate Oral Solution, Hydromorphone hydrochloric acid (HCl) tablets and Codeine Sulfate tablets.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Drugs - Generic
  • Sub-Industry: Pharmaceuticals
  • Exchange: NYSE
  • Symbol: LCI
  • CUSIP: 51601210
Key Metrics:
  • Previous Close: $24.23
  • 50 Day Moving Average: $22.87
  • 200 Day Moving Average: $25.91
  • P/E Ratio: 12.06
  • P/E Growth: 0.44
  • Market Cap: $890.38M
  • Current Quarter EPS Consensus Estimate: $3.28 EPS
Additional Links:
Lannett Company (NYSE:LCI) Chart for Monday, June, 27, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha